Skip Navigation



Hum. Reprod. Advance Access published online on January 14, 2009

Human Reproduction, doi:10.1093/humrep/den396
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
24/4/782    most recent
den396v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Meintjes, M.
Right arrow Articles by Madden, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meintjes, M.
Right arrow Articles by Madden, J. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates{dagger}

Marius Meintjes2,3, Samuel J. Chantilis1, David C. Ward1, James D. Douglas1, Alfred J. Rodriguez1, Ali R. Guerami1, David M. Bookout1, Brian D. Barnett1 and James D. Madden2

1 Institutional affiliations Presbyterian Hospital ARTS Program, Dallas, TX 75231, USA 2 Frisco Institute for Reproductive Medicine, Frisco, TX 75034, USA

3 Correspondence address. 8380 Warren Parkway, Suite 201 Frisco Texas 75034, USA. Fax: +1-972-377-2667; E-mail: mmeintjes{at}friscoinfertility.com

BACKGROUND: It has been speculated that the addition of proteins more complex than human serum albumin (HSA) to culture media may improve IVF outcomes. Whether the expense, labor and risk of adding additional human-derived protein to IVF media are warranted is a question unanswered.

METHODS: In a randomized controlled trial with couples undergoing routine IVF or ICSI, 528 patients were assigned to one of two treatment groups. Embryos were cultured in either media supplemented with HSA as a solitary protein supplement or in media supplemented with HSA+serum substitute supplement (SSS) from the 2PN stage until the time of embryo transfer. Clinical end-points monitored included implantation (total 1151 embryos) and live birth rates (total 528 patients).

RESULTS: The transfer of embryos cultured in HSA+SSS resulted in higher embryo implantation (289/571, 50.6% versus 254/580, 43.8%; difference 6.8% with 95% CI 1.0–12.7, P = 0.042) and live birth rates (167/266, 62.8% versus 142/262, 54.2%; difference 8.6% with 95% CI 0.1–17.3, P = 0.043) when compared with those of women whose embryos were cultured with HSA as the sole protein supplement.

CONCLUSIONS: SSS added to commercial HSA-supplemented embryo culture media resulted in an overall increase in implantation and live birth rates. It remains uncertain whether the use of human-derived blood products in culture media and the requirement for ultra-rigorous quality control measures make these findings applicable to the average IVF laboratory. Protein enrichment of media may significantly improve the blastocyst implantation rate, creating opportunities to transfer single blastocysts without compromising the live birth rate.


{dagger} Presented, in part, as a poster at the 58th Annual Meeting of the American Society of Reproductive Medicine, Seattle, Washington, Fertil Steril 2002;78(Suppl. 1):S251.

Submitted on July 14, 2008; resubmitted on September 25, 2008; accepted on October 6, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.